首页> 美国卫生研究院文献>Human Molecular Genetics >Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2
【2h】

Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2

机译:脆弱的X蛋白FMRP的丢失会通过肿瘤抑制因子p53和泛素E3连接酶Nedd4-2抑制稳态突触降尺度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Synaptic scaling allows neurons to homeostatically readjust synaptic strength upon chronic neural activity perturbations. Although altered synaptic scaling has been implicated to underlie imbalanced brain excitability in neurological disorders such as autism spectrum disorders and epilepsy, the molecular dysregulation and restoration of synaptic scaling in those diseases have not been demonstrated. Here, we showed that the homeostatic synaptic downscaling is absent in the hippocampal neurons of Fmr1 KO mice, the mouse model of the most common inherited autism, fragile X syndrome (FXS). We found that the impaired homeostatic synaptic downscaling in Fmr1 KO neurons is caused by loss-of-function dephosphorylation of an epilepsy-associated ubiquitin E3 ligase, neural precursor cell expressed developmentally down-regulated gene 4-2, Nedd4-2. Such dephosphorylation of Nedd4-2 is surprisingly caused by abnormally stable tumor suppressor p53 and subsequently destabilized kinase Akt. Dephosphorylated Nedd4-2 fails to elicit 14-3-3-dependent ubiquitination and down-regulation of the GluA1 subunit of AMPA receptor, and therefore impairs synaptic downscaling. Most importantly, using a pharmacological inhibitor of p53, Nedd4-2 phosphorylation, GluA1 ubiquitination and synaptic downscaling are all restored in Fmr1 KO neurons. Together, our results discover a novel cellular mechanism underlying synaptic downscaling, and demonstrate the dysregulation and successful restoration of this mechanism in the FXS mouse model.
机译:突触缩放使神经元在慢性神经活动扰动时能够稳态地重新调节突触强度。尽管已经暗示改变的突触缩放比例是神经系统疾病(例如自闭症谱系障碍和癫痫)中大脑兴奋性失衡的基础,但尚未证明这些疾病的分子失调和突触缩放比例的恢复。在这里,我们显示Fmr1 KO小鼠(最常见的遗传自闭症,脆弱X综合征(FXS)的小鼠模型)的海马神经元不存在稳态的突触降尺度。我们发现,Fmr1 KO神经元体内稳态突触缩小比例的降低是由癫痫相关泛素E3连接酶的功能丧失去磷酸化引起的,神经前体细胞表达了发育性下调的基因4-2,Nedd4-2。 Nedd4-2的这种去磷酸化令人惊讶地由异常稳定的肿瘤抑制因子p53和随后不稳定的激酶Akt引起。去磷酸化的Nedd4-2未能引起AMPA受体GluA1亚基的14-3-3-依赖性泛素化和下调,因此损害了突触的缩小。最重要的是,使用p53的药理抑制剂,Nedd4-2磷酸化,GluA1泛素化和突触缩小均在Fmr1 KO神经元中得以恢复。在一起,我们的结果发现了一种新的突触缩小尺度的细胞机制,并证明了FXS小鼠模型中这种机制的失调和成功恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号